P15812 (CD1E_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: T-cell surface glycoprotein CD1e, membrane-associated Short name=hCD1e Alternative name(s): R2G1 CD_antigen=CD1e Cleaved into the following chain:
| ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 388 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | T-cell surface glycoprotein CD1e, soluble is required for the presentation of glycolipid antigens on the cell surface. The membrane-associated form is not active. Ref.2 Ref.10 |
| Subunit structure | Heterodimer with B2M (beta-2-microglobulin). The association with B2M appears to be facilitated by the presence of the propeptide. |
| Subcellular location | T-cell surface glycoprotein CD1e, membrane-associated: Golgi apparatus membrane; Single-pass type I membrane protein. Early endosome. Late endosome. Note: Predominantly localized in the trans-Golgi network in immature dendritic cells, and as a cleaved, soluble protein in the lysosome lumen of mature dendritic cells. Ref.2 Ref.11 Ref.12 T-cell surface glycoprotein CD1e, soluble: Lysosome lumen Ref.2 Ref.11 Ref.12. |
| Tissue specificity | Expressed on cortical thymocytes, dendritic cells, Langerhans cells, on certain T-cell leukemias, and in various other tissues. Ref.2 |
| Post-translational modification | Mono-ubiquitinated. Proteolytically cleaved in late endosomes to yield a soluble form. Ref.2 Ref.11 Ref.12 |
| Polymorphism | Six alleles of CD1E are known. CD1E*01 has His-102/Gln-106/Ser-149/Arg-164/Leu-194, CD1E*02 has His-102/Arg-106/Ser-149/Arg-164/Leu-194, CD1E*03 (9L) has His-102/Gln-106/Ser-149/Trp-164/Leu-194, CD1E*04 (15L) has His-102/Gln-106/Ser-149/Arg-164/Pro-194, CD1E*05 has Arg-102/Arg-106/Ser-149/Arg-164/Leu-194 and CD1E*06 has His-102/Arg-106/Asn-149/Arg-164/Leu-194. The sequence shown is that of allele CD1E*01. |
| Sequence similarities | Contains 1 Ig-like (immunoglobulin-like) domain. |
| Sequence caution | The sequence CAA33100.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Adaptive immunity Immunity |
| Cellular component | Endosome Golgi apparatus Lysosome Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Immunoglobulin domain Signal Transmembrane Transmembrane helix |
| PTM | Disulfide bond Glycoprotein Ubl conjugation |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | antigen processing and presentation Inferred from electronic annotation. Source: InterPro immune responseNon-traceable author statement Ref.1. Source: UniProtKB |
| Cellular_component | Golgi membrane Inferred from electronic annotation. Source: UniProtKB-SubCell early endosomeInferred from electronic annotation. Source: UniProtKB-SubCell integral to plasma membraneNon-traceable author statement Ref.1. Source: UniProtKB late endosomeInferred from electronic annotation. Source: UniProtKB-SubCell lysosomal lumenInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Alternative products
| This entry describes 12 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P15812-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P15812-2) The sequence of this isoform differs from the canonical sequence as follows: 334-345: Missing. | ||||||
| Isoform 3 (identifier: P15812-3) The sequence of this isoform differs from the canonical sequence as follows: 268-290: YLRATLDVAAGEAAGLSCRVKHS → WIFHLSHPDLFDCDSYPGHIGCS 291-388: Missing. | ||||||
| Isoform 4 (identifier: P15812-4) The sequence of this isoform differs from the canonical sequence as follows: 248-302: Missing. 334-345: Missing. | ||||||
| Isoform 5 (identifier: P15812-5) The sequence of this isoform differs from the canonical sequence as follows: 119-209: YPFEIQILAG...AGESELKRKV → L | ||||||
| Isoform 6 (identifier: P15812-6) The sequence of this isoform differs from the canonical sequence as follows: 119-209: YPFEIQILAG...AGESELKRKV → L 334-345: Missing. | ||||||
| Isoform 7 (identifier: P15812-7) The sequence of this isoform differs from the canonical sequence as follows: 119-209: YPFEIQILAG...AGESELKRKV → L 248-302: Missing. 334-345: Missing. | ||||||
| Isoform 8 (identifier: P15812-8) The sequence of this isoform differs from the canonical sequence as follows: 20-208: Missing. | ||||||
| Isoform 9 (identifier: P15812-9) The sequence of this isoform differs from the canonical sequence as follows: 20-208: Missing. 334-345: Missing. | ||||||
| Isoform 10 (identifier: P15812-10) The sequence of this isoform differs from the canonical sequence as follows: 20-208: Missing. 268-290: YLRATLDVAAGEAAGLSCRVKHS → WIFHLSHPDLFDCDSYPGHIGCS 291-388: Missing. | ||||||
| Isoform 11 (identifier: P15812-11) The sequence of this isoform differs from the canonical sequence as follows: 20-208: Missing. 248-302: Missing. | ||||||
| Isoform 12 (identifier: P15812-12) The sequence of this isoform differs from the canonical sequence as follows: 20-208: Missing. 248-302: Missing. 334-345: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 19 | 19 | Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 20 – 388 | 369 | T-cell surface glycoprotein CD1e, membrane-associated | PRO_0000014582 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 20 – 31 | 12 | Removed in sCD1e | PRO_0000379780 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 32 – 388 | 357 | T-cell surface glycoprotein CD1e, soluble | PRO_0000379781 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 305 – 325 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 191 – 301 | 111 | Ig-like | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 47 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 84 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 230 ↔ 285 | By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 20 – 208 | 189 | Missing in isoform 8, isoform 9, isoform 10, isoform 11 and isoform 12. | VSP_037708 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 119 – 209 | 91 | YPFEI…LKRKV → L in isoform 5, isoform 6 and isoform 7. | VSP_037709 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 248 – 302 | 55 | Missing in isoform 4, isoform 7, isoform 11 and isoform 12. | VSP_037710 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 268 – 290 | 23 | YLRAT…RVKHS → WIFHLSHPDLFDCDSYPGHI GCS in isoform 3 and isoform 10. | VSP_037711 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 291 – 388 | 98 | Missing in isoform 3 and isoform 10. | VSP_037712 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 334 – 345 | 12 | Missing in isoform 2, isoform 4, isoform 6, isoform 7, isoform 9 and isoform 12. | VSP_037713 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 15 | 1 | G → E. Corresponds to variant rs3180089 [ dbSNP | Ensembl ]. | VAR_056035 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 102 | 1 | H → R in allele CD1E*05. Ref.7 Corresponds to variant rs2873587 [ dbSNP | Ensembl ]. | VAR_058324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 106 | 1 | Q → R in allele CD1E*02, allele CD1E*05 and CD1E*06. Ref.2 Ref.6 Ref.7 Corresponds to variant rs1065457 [ dbSNP | Ensembl ]. | VAR_010191 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 149 | 1 | S → N in allele CD1E*05. Ref.7 Corresponds to variant rs35116276 [ dbSNP | Ensembl ]. | VAR_058325 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 164 | 1 | R → W in allele CD1E*03. Ref.7 Ref.8 | VAR_010192 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 194 | 1 | L → P in allele CD1E*04; impairs localization to late endosomal compartments and lipid antigen presentation. Ref.8 Ref.13 | VAR_010193 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 209 | 1 | V → A in BAG64215. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 248 | 1 | E → G in BAG64215. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 37 – 46 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 59 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 62 – 68 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 69 – 72 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 75 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 79 – 82 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 87 – 111 | 25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 112 – 116 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 129 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 132 – 134 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 136 – 139 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 145 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 159 – 161 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 163 – 174 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 176 – 201 | 26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 202 – 205 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 222 – 224 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 228 – 230 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 232 – 234 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 236 – 238 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 241 – 244 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 260 – 262 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 263 – 265 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 266 – 269 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 271 – 273 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 277 – 280 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 285 – 288 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 290 – 292 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 300 – 302 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Two classes of CD1 genes." Calabi F., Jarvis J.M., Martin L., Milstein C. Eur. J. Immunol. 19:285-292(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells." Angenieux C., Salamero J., Fricker D., Cazenave J.-P., Goud B., Hanau D., de La Salle H. J. Biol. Chem. 275:37757-37764(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11 AND 12), VARIANT ARG-106, FUNCTION, INTERACTION WITH B2M, PROTEOLYTIC PROCESSING, TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Thymus. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE CD1E*01). |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES CD1E*01). |
| [6] | "Polymorphism of human CD1 genes." Han M., Hannick L.I., DiBrino M., Robinson M.A. Tissue Antigens 54:122-127(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-118, VARIANT ARG-106. |
| [7] | "Two novel CD1 E alleles identified in black African individuals." Tamouza R., Sghiri R., Ramasawmy R., Neonato M.G., Mombo L.E., Poirier J.C., Schaeffer V., Fortier C., Labie D., Girot R., Toubert A., Krishnamoorthy R., Charron D. Tissue Antigens 59:417-420(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-208 (ALLELES CD1E*05 AND CD1E*06), VARIANTS ARG-102; ARG-106; ASN-149 AND TRP-164. |
| [8] | "Identification of two novel human CD1E alleles." Mirones I., Oteo M., Parra-Cuadrado J.F., Martinez-Naves E. Tissue Antigens 56:159-161(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 120-208 (ALLELES CD1E*03 AND CD1E*04), VARIANTS TRP-164 AND PRO-194. |
| [9] | "Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens." Martin L.H., Calabi F., Milstein C. Proc. Natl. Acad. Sci. U.S.A. 83:9154-9158(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 209-301. |
| [10] | "Assistance of microbial glycolipid antigen processing by CD1e." de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.-F., Malm D., Berg T., Paoletti S., Maitre B., Mourey L., Salamero J., Cazenave J.-P., Hanau D., Mori L., Puzo G., De Libero G. Science 310:1321-1324(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "Control of the intracellular pathway of CD1e." Maitre B., Angenieux C., Salamero J., Hanau D., Fricker D., Signorino F., Proamer F., Cazenave J.-P., Goud B., Tourne S., de la Salle H. Traffic 9:431-445(2008) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, UBIQUITINATION, PROTEOLYTIC PROCESSING. |
| [12] | "The assembly of CD1e is controlled by an N-terminal propeptide which is processed in endosomal compartments." Maitre B., Angenieux C., Wurtz V., Layre E., Gilleron M., Collmann A., Mariotti S., Mori L., Fricker D., Cazenave J.P., van Dorsselaer A., Gachet C., de Libero G., Puzo G., Hanau D., de la Salle H. Biochem. J. 419:661-668(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION. |
| [13] | "A naturally occurring mutation in CD1e impairs lipid antigen presentation." Tourne S., Maitre B., Collmann A., Layre E., Mariotti S., Signorino-Gelo F., Loch C., Salamero J., Gilleron M., Angenieux C., Cazenave J.P., Mori L., Hanau D., Puzo G., De Libero G., de la Salle H. J. Immunol. 180:3642-3646(2008) [PubMed] [Europe PMC] [Abstract] Cited for: POLYMORPHISM, VARIANT PRO-194. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X14975 Genomic DNA. Translation: CAA33100.1. Sequence problems. AJ289111 mRNA. Translation: CAB93150.1. AJ289112 mRNA. Translation: CAB93151.1. AJ289113 mRNA. Translation: CAB93152.1. AJ289114 mRNA. Translation: CAB93153.1. AJ289115 mRNA. Translation: CAB93154.1. AJ289116 mRNA. Translation: CAB93155.1. AJ289117 mRNA. Translation: CAB93156.1. AJ289118 mRNA. Translation: CAB93157.1. AJ289119 mRNA. Translation: CAB93158.1. AJ289120 mRNA. Translation: CAB93159.1. AJ289121 mRNA. Translation: CAB93160.1. AJ289122 mRNA. Translation: CAB93161.1. AK303108 mRNA. Translation: BAG64215.1. AL121986 Genomic DNA. Translation: CAI10854.1. AL121986 Genomic DNA. Translation: CAI10855.1. AL121986 Genomic DNA. Translation: CAI10856.1. AL121986 Genomic DNA. Translation: CAI10857.1. AL121986 Genomic DNA. Translation: CAI10858.1. AL121986 Genomic DNA. Translation: CAI10859.1. AL121986 Genomic DNA. Translation: CAI10860.1. AL121986 Genomic DNA. Translation: CAI10861.1. AL121986 Genomic DNA. Translation: CAI10862.1. AL121986 Genomic DNA. Translation: CAI10863.1. AL121986 Genomic DNA. Translation: CAI10864.1. AL121986 Genomic DNA. Translation: CAI10865.1. CH471121 Genomic DNA. Translation: EAW52828.1. CH471121 Genomic DNA. Translation: EAW52830.1. CH471121 Genomic DNA. Translation: EAW52831.1. CH471121 Genomic DNA. Translation: EAW52832.1. CH471121 Genomic DNA. Translation: EAW52833.1. CH471121 Genomic DNA. Translation: EAW52834.1. CH471121 Genomic DNA. Translation: EAW52835.1. CH471121 Genomic DNA. Translation: EAW52837.1. CH471121 Genomic DNA. Translation: EAW52838.1. CH471121 Genomic DNA. Translation: EAW52839.1. CH471121 Genomic DNA. Translation: EAW52840.1. AF142669 Genomic DNA. Translation: AAD37582.1. AH010757 Genomic DNA. Translation: AAK52913.1. AH010758 Genomic DNA. Translation: AAK52914.1. AJ251334 Genomic DNA. Translation: CAB82829.1. AJ251335 Genomic DNA. Translation: CAC07175.1. M14666 Genomic DNA. Translation: AAA51937.1. | ||||||||||||
| IPI | IPI00418592. IPI00427974. IPI00427982. IPI00427983. IPI00477640. IPI00478106. IPI00552171. IPI00642364. IPI00644470. IPI00645910. IPI00646173. IPI00647002. | ||||||||||||
| PIR | HLHUR2. S07716. | ||||||||||||
| RefSeq | NP_001036048.1. NM_001042583.2. NP_001036049.1. NM_001042584.2. NP_001036050.1. NM_001042585.2. NP_001036051.1. NM_001042586.2. NP_001036052.1. NM_001042587.2. NP_001172036.1. NM_001185107.1. NP_001172037.1. NM_001185108.1. NP_001172039.1. NM_001185110.1. NP_001172041.1. NM_001185112.1. NP_001172042.1. NM_001185113.1. NP_001172044.1. NM_001185115.1. NP_112155.2. NM_030893.3. | ||||||||||||
| UniGene | Hs.249217. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P15812. | ||||||||||||
| ModBase | Search... | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 254763260. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P15812. | ||||||||||||
| PRIDE | P15812. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000368154; ENSP00000357136; ENSG00000158488. ENST00000368155; ENSP00000357137; ENSG00000158488. ENST00000368156; ENSP00000357138; ENSG00000158488. ENST00000368157; ENSP00000357139; ENSG00000158488. ENST00000368160; ENSP00000357142; ENSG00000158488. ENST00000368161; ENSP00000357143; ENSG00000158488. ENST00000368163; ENSP00000357145; ENSG00000158488. ENST00000368164; ENSP00000357146; ENSG00000158488. ENST00000368165; ENSP00000357147; ENSG00000158488. ENST00000368166; ENSP00000357148; ENSG00000158488. ENST00000368167; ENSP00000357149; ENSG00000158488. ENST00000452291; ENSP00000416228; ENSG00000158488. | ||||||||||||
| GeneID | 913. | ||||||||||||
| KEGG | hsa:913. | ||||||||||||
| UCSC | uc001fry.3. human. uc001frz.3. human. uc001fsa.3. human. uc001fsc.3. human. uc001fsd.3. human. uc001fse.3. human. uc001fsf.3. human. uc001fsg.3. human. uc001fsh.3. human. uc001fsj.3. human. uc001fsk.3. human. uc010pig.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 913. | ||||||||||||
| GeneCards | GC01P158323. | ||||||||||||
| HGNC | HGNC:1638. CD1E. | ||||||||||||
| MIM | 188411. gene. | ||||||||||||
| neXtProt | NX_P15812. | ||||||||||||
| PharmGKB | PA26197. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG26626. | ||||||||||||
| HOVERGEN | HBG004453. | ||||||||||||
| InParanoid | P15812. | ||||||||||||
| KO | K06448. | ||||||||||||
| OrthoDB | EOG44XJH1. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P15812. | ||||||||||||
| Bgee | P15812. | ||||||||||||
| CleanEx | HS_CD1E. | ||||||||||||
| Genevestigator | P15812. | ||||||||||||
| GermOnline | ENSG00000158488. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 1 hit. 3.30.500.10. 1 hit. | ||||||||||||
| InterPro | IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003597. Ig_C1-set. IPR011161. MHC_I-like_Ag-recog. IPR011162. MHC_I/II-like_Ag-recog. [Graphical view] | ||||||||||||
| Pfam | PF07654. C1-set. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00407. IGc1. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF54452. MHC_I/II-like_Ag-recog. 1 hit. | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| GenomeRNAi | 913. | ||||||||||||
| NextBio | 3766. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CD1E_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P15812 Secondary accession number(s): B4DZV3 Q9Y5M3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
